Prestige BioPharma Limited (950210.KS)
KRW 15050.0
(-4.57%)
KRW 15050.0
(-4.57%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -48.02 Billion | -60.27 Billion | -45.9 Billion | -15.44 Billion | -12.42 Billion | 3.77 Billion |
| Net Income | -55.09 Billion | -2.85 Billion | -211.45 Billion | -7.39 Billion | -14.99 Billion | -1.44 Billion |
| Depreciation & Amortization | 16.26 Billion | 11.64 Billion | 3.86 Billion | 1.66 Billion | 1.18 Billion | 573.67 Million |
| Deferred income taxes | - | -39.46 Billion | 181.67 Billion | -15.02 Billion | - | - |
| Stock-based compensation | 52.41 Million | 1.94 Billion | 3.77 Billion | 2.95 Billion | - | - |
| Change in working capital | 11.05 Billion | -18.72 Billion | -19.04 Billion | 2.07 Billion | -3.02 Billion | 7.55 Billion |
| Other non-cash items | -5.69 Billion | -12.82 Billion | -4.73 Billion | 276.28 Million | 4.41 Billion | 1.67 Billion |
| Investing Cash Flow | 132.46 Billion | -148.61 Billion | -184.68 Billion | -20.91 Billion | -18.03 Billion | -37.64 Billion |
| Investments in PPE | -27.99 Billion | -65.61 Billion | -68.11 Billion | -18.11 Billion | -18.73 Billion | -35.39 Billion |
| Acquisitions | 51.25 Million | 40.03 Billion | 26.44 Billion | - | - | - |
| Investment purchases | - | -133.82 Billion | -25.23 Billion | - | - | - |
| Sales/Maturities of investments | 159.98 Billion | -16.12 Billion | -26.44 Billion | - | - | - |
| Other Investing Activities | 73.8 Million | 26.91 Billion | -91.33 Billion | -2.8 Billion | 694.1 Million | -2.24 Billion |
| Financing Cash Flow | -1.46 Billion | 53.18 Billion | -4.5 Billion | 454.51 Billion | 66.14 Billion | 39.73 Billion |
| Debt repayment | -823.6 Million | -876.01 Million | -2.91 Billion | -487.31 Million | -66.38 Billion | -39.73 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.3 Billion | - | - | 466.09 Billion | - | - |
| Other Financing Activities | -1.94 Billion | 54.05 Billion | -1.58 Billion | -11.08 Billion | 132.53 Billion | 34.05 Thousand |
| Accounts receivables | 4.28 Billion | -6.41 Billion | 179.2 Million | 1.24 Billion | 9.59 Billion | -3.43 Billion |
| Accounts payables | 2.46 Billion | -316.64 Million | 1.64 Billion | -1.06 Billion | - | - |
| Inventory | 7.75 Billion | -10.03 Billion | -24.04 Billion | 147.25 Thousand | - | - |
| Other working capital | -3.44 Billion | -1.95 Billion | 3.17 Billion | 1.88 Billion | -12.61 Billion | 10.99 Billion |
| Cash at beginning of period | 126.9 Billion | 274.72 Billion | 487.84 Billion | 43.49 Billion | 10.17 Billion | 3.71 Billion |
| Cash at end of period | 210.48 Billion | 125.9 Billion | 249.56 Billion | 461.37 Billion | 45.78 Billion | 9.82 Billion |
| Capital Expenditure | -27.99 Billion | -65.61 Billion | -68.11 Billion | -18.11 Billion | -18.73 Billion | -35.39 Billion |
| Effect of forex changes on cash | 608.72 Million | 6.88 Billion | -3.17 Billion | -277.54 Million | -72.67 Million | 236.49 Million |
| Net cash flow / Change in cash | 83.58 Billion | -148.81 Billion | -238.27 Billion | 417.88 Billion | 35.6 Billion | 6.1 Billion |
| Free Cash Flow | -76.01 Billion | -125.89 Billion | -114.01 Billion | -33.55 Billion | -31.15 Billion | -31.61 Billion |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.05 Billion | -1.44 Billion | -13.02 Billion | -17.03 Billion | -2.85 Billion | -15.33 Billion |
| Depreciation & Amortization | - | 4.47 Billion | 3.84 Billion | 3.41 Billion | 11.64 Billion | 3.41 Billion |
| Deferred income taxes | - | - | - | - | -39.46 Billion | - |
| Stock-based compensation | - | - | - | - | 1.94 Billion | - |
| Change in working capital | - | - | - | - | -18.72 Billion | - |
| Other non-cash items | -8.57 Billion | -4.92 Billion | -2.33 Billion | 1.33 Billion | -12.82 Billion | -12.87 Billion |
| Investing Cash Flow | 16.72 Billion | -6.6 Billion | 131.3 Billion | -8.94 Billion | -148.61 Billion | -133.74 Billion |
| Investments in PPE | -6.72 Billion | -6.92 Billion | -6.23 Billion | -8.07 Billion | -65.61 Billion | -8.91 Billion |
| Acquisitions | - | -469.09 Thousand | -18.17 Million | 69.94 Million | 40.03 Billion | -72.98 Million |
| Investment purchases | - | - | -1.00 | -69.94 Million | -133.82 Billion | -133.69 Billion |
| Sales/Maturities of investments | 23.02 Billion | 301.26 Million | 134.82 Billion | 1.72 Billion | -16.12 Billion | 133.69 Billion |
| Other Investing Activities | -15.03 Million | 21.16 Million | 2.73 Billion | -2.59 Billion | 26.91 Billion | -124.76 Billion |
| Financing Cash Flow | -504.01 Million | 119.95 Million | -3.21 Billion | 2.12 Billion | 53.18 Billion | 10.51 Billion |
| Debt repayment | -2.13 Million | -269.98 Million | -3.16 Billion | -2.61 Billion | -876.01 Million | -65.96 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -4.9 Million | 874.36 Million | 436.46 Million | - | - | - |
| Other Financing Activities | -501.23 Million | - | -480.74 Million | 4.74 Billion | 54.05 Billion | 10.57 Billion |
| Accounts receivables | - | - | - | - | -6.41 Billion | - |
| Accounts payables | - | - | - | - | -316.64 Million | - |
| Inventory | - | - | - | - | -10.03 Billion | - |
| Other working capital | - | - | - | - | -1.95 Billion | - |
| Cash at beginning of period | 204.8 Billion | 64.05 Billion | 62.44 Billion | 124.84 Billion | 274.72 Billion | 272.6 Billion |
| Cash at end of period | 210.48 Billion | 41.38 Billion | 64.05 Billion | 104.57 Billion | 125.9 Billion | 125.9 Billion |
| Capital Expenditure | -6.72 Billion | -6.92 Billion | -6.23 Billion | -8.07 Billion | -65.61 Billion | -8.91 Billion |
| Effect of forex changes on cash | 1.67 Billion | -2.03 Billion | 2.13 Billion | -1.17 Billion | 6.88 Billion | 1.83 Billion |
| Net cash flow / Change in cash | 5.67 Billion | -22.66 Billion | 1.61 Billion | -20.26 Billion | -148.81 Billion | -146.69 Billion |
| Free Cash Flow | -20.14 Billion | -17.78 Billion | -17.75 Billion | -20.35 Billion | -125.89 Billion | -33.7 Billion |
WYGPF
TEMPF
LUDN
LIFFF
300420
DNNGY